Clinical Trials Browser

Phase 3 × ferric carboxymaltose × 90 days × Clear all

NCT05226169 2026-04-03

Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

Phase 3 Recruiting

Gastrointestinal

Advanced Gastric Carcinoma